Drug Trial Radar · NCT05552755
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Last checked: Nov 19, 2026Latest source record: Jun 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
67
Planned (sponsor's estimate)
Start
Jul 10, 2023
Primary completion
Jun 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Recursion Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, two-part trial in participants with FAP.
Conditions
- Familial Adenomatous Polyposis
Interventions
REC-4881Drug
REC-4881 capsules
PlaceboDrug
Placebo capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Maximum (Peak) Plasma Drug Concentration (Cmax) of REC-4881Time frame: Day 1 through Day 43
- Part 1: Time to Reach Cmax (Tmax) of REC-4881Time frame: Day 1 through Day 43
- Part 1: Area Under the Plasma Concentration-time Curve (AUC) of REC-4881Time frame: Day 1 through Day 43
- Part 2: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Day 1 through up to Week 37
- Part 2: Number of Participants With Dose-limiting Toxicities (DLTs)Time frame: First 28 days of treatment
- Part 2: Number of Participants Who Discontinued TreatmentTime frame: Day 1 through up to Week 37
- Part 2: Number of Participants With Dose Modification Due to ToxicityTime frame: Day 1 through up to Week 37
- Part 2: Percent Change From Baseline in Polyp BurdenTime frame: Baseline, up to Week 37
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic - Scottsdale
Scottsdale, Arizona · Active not recruiting
Del Sol Research Management
Tucson, Arizona · Withdrawn
Medical Associates Research Group
San Diego, California · Withdrawn
GI Pros
Naples, Florida · Withdrawn
Digestive and Liver Center of Florida
Orlando, Florida · Terminated
Gastroenterology Health Partners, PLLC
New Albany, Indiana · Withdrawn
Tandem Clinical Research
Marrero, Louisiana · Terminated
Corewell Health (Spectrum Health Hospitals Colorectal Cancer Multis)
Grand Rapids, Michigan · Active not recruiting
Mayo Clinic - Rochester
Rochester, Minnesota · Active not recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Gastro One-8110 Walnut Rs
Cordova, Tennessee · Terminated
Vanderbilt Digestive Center
Nashville, Tennessee · Recruiting
Genetic Cancer Prevention Clinic - UT Southwestern
Dallas, Texas · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
Huntsman Cancer Institute and University of Utah
Salt Lake City, Utah · Recruiting
Benaroya Research Institute at Virginia Mason
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.